BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Diacrin Incorporated

Diacrin is developing transplantable cells for the treatment of human diseases which are characterized by cell dysfunction or cell death and for which current therapies are either inadequate or nonexistent. Products under development for the treatment of neurological disorders include: NeuroCell(TM)-PD for Parkinson's disease and NeuroCell(TM)-HD for Huntington's disease, both of which are being developed in a joint venture with Genzyme Corporation ("Genzyme"), NeuroCell(TM)-FE for focal epilepsy, porcine neural cells for stroke and intractable pain and spinal cord cells for spinal cord injury. Also under development are hepatocytes for acute liver failure and for cirrhosis, myoblasts for cardiac disease and retinal epithelial cells for macular degeneration.


Contact Details:
Building 96 13th Street
Charlestown
MA
02129
United States of America
Tel:617 242 9100
Fax:617 242 0070
Email:clinicalinfo@diacrin.com
WWW:

www.diacrin.com/




Loading...

Recent Publications by Diacrin Incorporated:

An overview of myoblast transplantation for myocardial regeneration.
Regenerative medicine represents a new frontier in treatment of disease,...
16th September, 2005
Diacrin, Inc., Charlestown, MA, USA. Am Heart Hosp J. 2005 Summer;3(3):146-52.
A novel monoclonal antibody inhibits the immune response of human cells against porcine cells: identification of a porcine antigen homologous to CD58.
BACKGROUND: Human CD58 is an adhesion molecule that interacts with CD2 on...
1st July, 2004
Diacrin, Inc. Charlestown, MA, USA. Transplantation. 2004 Apr 27;77(8):1288-94.
Long-term survival of fetal porcine lateral ganglionic eminence cells in the hippocampus of rats.
Embryonic porcine brain tissue from the lateral ganglionic eminence was...
20th June, 2000
Diacrin, Inc., Department of Cell Transplantation, Charlestown Navy Yard, J Neurosci Res. 1999 Jun 15;56(6):581-94.

Diacrin Incorporated Patents:

US Patent No.Title
6821779 Methods for storing neural cells
6204053 Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases
6140116 Isolated and modified porcine cerebral cortical cells
6096537 Cells with multiple altered epitopes on a surface antigen for use in transplantation
5961972 Isolated porcine pancreatic cells for use in treatment of diseases characterized by insufficient insulin activity

View more Diacrin Incorporated patents.

Diacrin Incorporated (DCRN) Financial information Links from Barchart

DCRN Quote from from Barchart.com
DCRN Chart from from Barchart.com
DCRN Profile from from Barchart.com
DCRN Opinion from from Barchart.com

View more Diacrin Incorporated finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 145 times since April 2007, the link to the organisation's website has been followed 32 times

Recent Search Terms used to find this page: @diacrin.com | neurocell UK | diacrin spinal cord injury | diacrin.com | Diacrin Incorporated | .

Search for more companies in Charlestown

Search for more companies in MA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Diacrin Incorporated
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.